4 March 2024
MOLECULAR ENERGIES PLC
("Molecular" or the "Company")
Strategic progress in Green House Capital Group
EIS advance assurance granted
Molecular Energies (AIM: MEN), the international energy company, provides an update on Green House Capital Group PLC (Molecular 75% shareholder).
Key Points:
· Green House Capital Group ("GHC"), has received advance assurance from HM Revenue & Customs ("HMRC") for prospective investment under the Enterprise Investment Scheme ("EIS")
· Further strategic progress set out in a new verified GHC Investor Presentation published on website of GHC at www.ghcplc.com
GREEN HOUSE CAPITAL GROUP
EIS
GHC has been granted advance assurance for prospective EIS investment under the
Subject to certain conditions being met by the company and the investor, the scheme enables a qualifying investor with a
Based on the EIS advance assurance given by HMRC, the directors of GHC also believe that an investment in the company would constitute a 'qualifying holding' for a Venture Capital Trust ("VCT").
This is a positive development for GHC and its future funding plans, whether through IPO or other new share issue as an independent company to enable the expansion and growth of the business.
STRATEGIC PROGRESS OF GHC
GHC is pleased to announce that material progress has been made in various businesses of that Group. A summary is set out below and more details are described in the Investor Presentation.
Hyso
- Internationally applicable biochar carbon removal projects with significant potential for carbon offsets and products for agriculture, cement, and asphalt industries. Targeted to commence production in H2 2024
- Feedstock and offtake agreements in place
Dual Fuel
- Testing shows 31% diesel retardation (reduction of diesel displaced by hydrogen)
- Further shows 29% increase in fuel efficiency giving more energy produced per unit of fuel
- Company moving into mobile dual fuel and hydrogen mobile generators for off-grid contractors and plant hire businesses
- Offtake clients in place
- Business with international applicability anticipated to commence in latter part of 2024
Aton 6
- Advanced negotiations with significant clients for company services in a wide variety of sectors
- Business model of medium-to-long-term contracts with positive cash flow
- Benefits from inter-group and related party businesses
Peter Levine, Chair, commented:
"The MEN Board believes that significant value has already been generated throughout the Green House businesses. The grant of EIS advance assurance from HMRC is a important milestone that will assist in funding the growth and expansion Green House.
"We look forward to being able to report on further progress as soon as possible."
For more information, please visit www.molecularenergiesplc.com or contact:
Molecular Energies PLC Peter Levine, Chairman Rob Shepherd, Group FD
|
+44 (0)20 7016 7950 |
Cavendish Capital Markets Limited (Nominated Adviser & Broker) Simon Hicks, George Dollemore
|
+44 (0)20 7220 0500 |
Tavistock (Financial PR & IR) Simon Hudson, Nick Elwes, Saskia Sizen |
+44 (0)20 7920 3150 |
Notes to Editors
Molecular Energies PLC is an AIM listed company at the forefront of energy development and has interests across the energy spectrum, from an oil and gas project to the green and alternative energy sector.
The Company currently has an oil exploration asset in
Activities in the green and alternative energy space are being carried out direct through Molecular and under the Green House Capital brand and through AIM listed Atome Energy PLC, a green hydrogen, ammonia, and fertiliser company operating in
With a strong strategic and institutional base of support, no third-party financial debt and a Chairman whose interests as the largest shareholder are aligned to those of its shareholders, Molecular gives
-ends-
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.